Aurobindo Pharma gets USFDA nod for generic anti-infective drug

The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Polymyxin B.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news